Rubella Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Measles-mumps-rubella vaccine at 6  months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial
AbstractBackgroundMeasles is a highly contagious and serious infection. Before the introduction of vaccination, measles caused yearly epidemics putting vulnerable children at risk of brain damage and death. Despite safe and cost-effective vaccines, measles remains a leading cause of death in children globally. Due to insufficient vaccine coverage and low levels of in utero transferred antibodies from vaccinated mothers, outbreaks of measles in Denmark and other high-income countries are observed at increasing frequency.The current vaccine was introduced in Denmark in 1987 as a one-shot measles-mumps-rubella vaccine at 15 â...
Source: Trials - December 10, 2020 Category: Research Source Type: clinical trials

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
Conditions:   Pneumococcal Immunisation;   Diphtheria Immunisation;   Tetanus Immunisation;   Pertussis Immunisation;   Hepatitis B Immunisation;   Haemophilus Influenzae Type b Immunisation;   Polio Immunisation;   Measles Immunisation;   Rubella Immunisation;   Varicella Immunisation;   Mumps Immunisation Interventions:   Biological: SP0202-IIb Pneumococcal Conjugate Vaccine formulation 1;   Biological: SP0202-VI Pneumococcal Conjugate Vaccine formulation 2;   Biological: SP0202-VII Pneumococcal Conjugate Vaccine formulation 3;   Biological: Varicella Virus Vaccine Live;   Biological: M...
Source: ClinicalTrials.gov - May 22, 2020 Category: Research Source Type: clinical trials

Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial
Conditions:   Measles;   Rubella;   Vaccination;   Healthy Interventions:   Biological: Measles Rubella Vaccine (MRV-SC);   Biological: MRV-MNP;   Other: PLA-MNP;   Other: PLA-SC Sponsors:   Micron Biomedical, Inc;   Medical Research Council;   Centers for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2020 Category: Research Source Type: clinical trials